SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 53, Issue 10, Pages 777-786
Publisher
Wiley
Online
2013-05-09
DOI
10.1002/mc.22033
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The molecular pathogenesis of head and neck squamous cell carcinoma
- (2012) S. Michael Rothenberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of Neurofilament Light Polypeptide in Head and Neck Cancer Chemoresistance
- (2012) B. Chen et al. MOLECULAR CANCER RESEARCH
- HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition
- (2011) Karuppaiyah Selvendiran et al. CANCER BIOLOGY & THERAPY
- GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response
- (2011) Baishen Chen et al. CANCER LETTERS
- Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells
- (2011) Shuling Huang et al. CANCER LETTERS
- How do real tumors become resistant to cisplatin?
- (2011) Piet Borst et al. CELL CYCLE
- Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
- (2011) Martin C. Boonstra et al. CURRENT PHARMACEUTICAL DESIGN
- IMP3 Is a Novel Biomarker to Predict Metastasis and Prognosis of Tongue Squamous Cell Carcinoma
- (2011) Hai-Gang Li et al. JOURNAL OF CRANIOFACIAL SURGERY
- Maximizing survival and minimizing toxicity
- (2011) Bruce E. Brockstein et al. Nature Reviews Clinical Oncology
- Evaluation of the Association of Urokinase Plasminogen Activator System Gene Polymorphisms with Susceptibility and Pathological Development of Hepatocellular Carcinoma
- (2010) Chia-Jui Weng et al. ANNALS OF SURGICAL ONCOLOGY
- MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF- B signals in gastric cancer cells
- (2010) J. S. Park et al. CARCINOGENESIS
- Integrating biomarkers into clinical trials: methodological issues for a new paradigm in nonsmall cell lung cancer
- (2010) Gérard Zalcman et al. CURRENT OPINION IN ONCOLOGY
- Down-regulated expression of SERPIN genes located on chromosome 18q21 in oral squamous cell carcinomas
- (2010) Shiiba ONCOLOGY REPORTS
- Downregulation of uPAR and Cathepsin B Induces Apoptosis via Regulation of Bcl-2 and Bax and Inhibition of the PI3K/Akt Pathway in Gliomas
- (2010) Ramarao Malla et al. PLoS One
- Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer
- (2010) Charlotte E. Almasi et al. PROSTATE
- Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3
- (2009) Rebecca J. Leeman-Neill et al. CARCINOGENESIS
- Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma
- (2009) W. A. Michaud et al. CLINICAL CANCER RESEARCH
- The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling
- (2009) Francesco Blasi et al. FEBS LETTERS
- Urokinase plasminogen activator system as a potential target for cancer therapy
- (2009) Ahmed H Mekkawy et al. Future Oncology
- Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation
- (2009) Guido B. van den Broek et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma
- (2009) Yukio Yamano et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of cell signalling by uPAR
- (2009) Harvey W. Smith et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Prognostic Significance of Growth Factors and the Urokinase-Type Plasminogen Activator System in Pancreatic Ductal Adenocarcinoma
- (2009) Aiqun Xue et al. PANCREAS
- Elevated Expression of Glutathione S-Transferase and p53 Confers Poor Prognosis in Head and Neck Cancer Patients Treated with Chemoradiotherapy but not Radiotherapy Alone
- (2008) L. Schumaker et al. CLINICAL CANCER RESEARCH
- Current concepts for the management of head and neck cancer: Chemotherapy
- (2008) Pol M. Specenier et al. ORAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now